Dentsply International | XRAY - Current Liabilities

Stock Price
10.07
Daily Change
-0.34 -3.27%
Monthly
-16.71%
Yearly
-39.70%
Q2 Forecast
10.77

Dentsply International reported $1.21B in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
3M USD 9.03B 563M Mar/2026
Agilent USD 2.23B 113M Dec/2025
Align Technology USD 1.91B 14.16M Mar/2026
Bruker USD 1.36B 75.9M Mar/2026
Cardinal Health USD 41.99B 1.33B Mar/2026
Charles River Laboratories USD 1.09B 26.61M Mar/2026
Cooper Companies USD 1.6B 482.9M Dec/2025
CVS Health USD 86.41B 2.29B Mar/2026
Danaher USD 7.46B 653M Mar/2026
Dentsply International USD 1.21B 136M Mar/2026
Henry Schein USD 3.3B 69M Mar/2026
Idexx Laboratories USD 1.3B 151.04M Mar/2026
Illumina USD 1.57B 19M Mar/2026
Integra LifeSciences USD 346.85M 109.14M Mar/2026
Intuitive Surgical USD 2.51B 3.2M Mar/2026
IQVIA Holdings USD 8.33B 9M Mar/2026
McKesson USD 67.02B 1.11B Mar/2026
Medtronic USD 9.5B 440M Dec/2025
Mettler Toledo International USD 1.11B 89.76M Mar/2026
Owens Minor USD 1.2B 256.03M Mar/2026
Repligen USD 126.21M 9.62M Mar/2026
Revvity USD 1.24B 92.6M Mar/2026
Smith & Nephew USD 1.54B 236M Dec/2025
Stryker USD 6.32B 1.48B Mar/2026
Thermo Fisher Scientific USD 14.62B 568M Mar/2026
Veradigm USD 230.31M 22.78M Dec/2022
Waters USD 1.24B 11.8M Dec/2025
Zimmer Biomet Holdings USD 2.86B 280.6M Mar/2026
Zoetis USD 2.05B 182M Mar/2026